Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.

Surgery today - 1 Sept 2016

Ohba Taro, Toyokawa Gouji, Osoegawa Atsushi, Hirai Fumihiko, Yamaguchi Masafumi, Taguchi Ken-Ichi, Seto Takashi, Takenoyama Mitsuhiro, Ichinose Yukito, Sugio Kenji

Abstract excerpt

BACKGROUND AND PURPOSE: The EGFR, K-ras, EML4-ALK, and BRAF genes are oncogenic drivers of lung adenocarcinoma. We conducted this study to analyze the mutations of these genes in stage I adenocarcinoma. METHODS: The subjects of this retrospective study were 256 patients with resected stage I lung adenocarcinoma. We analyzed mutations of the EGFR, K-ras, and BRAF genes, and the EML4-ALK fusion gene. We also...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Genes, erbB-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Microtubule-Associated Proteins

Share to Neoplasm Recurrence, Local

Share to Proto-Oncogene Proteins B-raf

Share to Receptor Protein-Tyrosine Kinases

Share to Serine Endopeptidases

Source

Identifiers

PMID: 26711128
DOI: 10.1007/s00595-015-1295-z

Genes

ALK
EML4
EGFR
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.PMID 26711128Read ↗

Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.Semantic proximity Read ↗

Clinicopathological and prognostic features of surgically resected pathological stage I lung adenocarcinoma harboring epidermal growth factor receptor and K-ras mutation.Semantic proximity Read ↗

Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages.Semantic proximity Read ↗

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.Semantic proximity Read ↗

Outcomes After Surgical Resection of Early-stage Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations.Semantic proximity Read ↗

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.Semantic proximity Read ↗

Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.Semantic proximity Read ↗

The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.Semantic proximity Read ↗

Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.Semantic proximity Read ↗

The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.Semantic proximity Read ↗

A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?Semantic proximity Read ↗

EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.